DBS: A UK (MHRA) regulatory perspective

Bioanalysis

Volumn 2, Issue 8, 2010, Pages 1363-1364

  Beharry, Michelle ^a  

^a MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANALYTIC METHOD; ANIMAL TESTING ALTERNATIVE; BLOOD SAMPLING; DRIED BLOOD SPOT SAMPLING; DRUG EXPOSURE; DRUG RESEARCH; DRUG SAFETY; GOOD LABORATORY PRACTICE; GOVERNMENT REGULATION; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROCESS OPTIMIZATION; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TOXICOLOGY; UNITED KINGDOM; VALIDATION PROCESS; ANIMAL; ARTICLE; BLOOD; BLOOD ANALYSIS; DESICCATION; GOVERNMENT; LEGAL ASPECT; METHODOLOGY; PHARMACOKINETICS;

DRUG;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; DESICCATION; GOVERNMENT AGENCIES; GOVERNMENT REGULATION; GREAT BRITAIN; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; TOXICOLOGY;

EID: 79953138888     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.109     Document Type: Review

References (1)

1. Spooner N, Lad R, Barfeld M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal. Chem. 81(4), 1557-1563 (2009).